0001209191-20-039815.txt : 20200701
0001209191-20-039815.hdr.sgml : 20200701
20200701172208
ACCESSION NUMBER: 0001209191-20-039815
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200629
FILED AS OF DATE: 20200701
DATE AS OF CHANGE: 20200701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arkowitz David
CENTRAL INDEX KEY: 0001296999
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37695
FILM NUMBER: 201006113
MAIL ADDRESS:
STREET 1: C/O FLEXION THERAPEUTICS, INC.
STREET 2: 10 MALL ROAD, SUITE 301
CITY: BURLINGTON
STATE: MA
ZIP: 01803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001445283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 80 GUEST STREET
STREET 2: 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-225-0096
MAIL ADDRESS:
STREET 1: 80 GUEST STREET
STREET 2: 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC
DATE OF NAME CHANGE: 20080916
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-29
0
0001445283
PROTEOSTASIS THERAPEUTICS, INC.
PTI
0001296999
Arkowitz David
C/O PROTEOSTASIS THERAPEUTICS, INC.
80 GUEST STREET, SUITE 500
BOSTON
MA
02135
1
0
0
0
Stock Option (Right to Buy)
1.39
2020-06-29
4
A
0
17400
0.00
A
2030-06-29
Common Stock
17400
17400
D
These securities shall vest and become exercisable in equal quarterly installments starting on September 29, 2020 until the option is fully vested and exercisable on June 29, 2021, subject to the Reporting Person continuing to provide services to the Issuer.
/s/ Janet Smart, Attorney-in-Fact
2020-07-01